Remember when marijuana used to be taboo? Back when Cheech & Chong – a comedy duo who tapped into the height of the cultural weed zeitgeist during the ‘70s – pushed the envelope to further their drug-fueled counterculture movement, weed smokers were still mostly marginalized.
The War on Drugs was in full swing, as Richard Nixon passed the Controlled Substances Act, labeled marijuana a Schedule 1 drug – listing pot next to cocaine and heroin as an extremely dangerous, extremely illegal substance with no “accepted medical use.”
So much for that…
Today, there’s no War on Drugs. The global legal marijuana market measures $17 BILLION, and it is growing at a 40% per-year pace.
And Luke sees two potential weed stocks worth investing in right now, which we’ve featured in our Innovation Investor Focused Portfolio (Get the details by watching this video, subscribing, and accessing Luke’s Plant Power portfolio).
Decades of pro-marijuana counter protesters, lobbyists, openly receptive musicians and actors, and so much more, helped reform marijuana’s image from the fearful days of Reefer Madness.
But mostly, emerging science changed public perception, paving the path for legalization and a “Marijuana Boom.”
Specifically, an abundance of academic research came out in the 2000s, which unpacked marijuana’s medical benefits. At the same time, Hollywood went from Cheech & Chong alone to portraying weed as a friendly, “fun” drug, in movies like Harold & Kumar, Step Brothers, Half Baked, How High, Friday, Dazed and Confused, Smiley Face, Super High Me, and so much more.
Marijuana became destigmatized…
Consumer attitudes shifted…
Changing public perception turned into growing public demand for legalization…
A few protests and bills later, marijuana wasn’t just legalized – it turned into one of the hottest consumer markets in the world.
If you missed out on investing early in the marijuana boom, don’t worry.
Right now, another Schedule-1 drug is in the first inning of following in marijuana’s explosive footsteps: psychedelics.
Yes. Those psychedelics. Magic mushrooms. LSD. MDMA. DMT.
For years and years, society has frowned up psychedelics as hard drugs to be avoided – but things weren’t always like that…
Let’s rewind 70 years.
Back in the 1950s, a group of pioneering psychiatrists in California led by Humphry Osmond were actively experimenting with psychedelics and finding that hallucinogenic drugs had immense therapeutic potential.
But sociopolitical backlash against “hippie culture” in the 1960s halted their research, and in 1970, psychedelics landed on Nixon’s Schedule-1 drug list.
The book was closed on psychedelic research.
Until the 2010s.
When the academic world reopened that book, and discovered a world of opportunity and untapped potential…
A pair of recent Johns Hopkins studies have found that the active ingredient in “magic mushrooms” (something called psilocybin) can…
Read more:2 Psychedelic Stocks With 10X ‘Shroom Boom’ Potential